Literature DB >> 2508661

Antiphospholipid antibodies and recurrent pregnancy loss.

D A Triplett1.   

Abstract

Antiphospholipid antibodies (APA) have recently been linked to a variety of clinical findings including arterial and venous thrombosis, recurrent spontaneous abortions and fetal loss, as well as thrombocytopenia. These observations have stimulated multidisciplinary interest in the laboratory identification of APA and the clinical management of patients with positive tests for APA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508661     DOI: 10.1111/j.1600-0897.1989.tb00639.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  6 in total

1.  Fibrinolytic balance and lupus anticoagulant in patients with repeated spontaneous fetal loss.

Authors:  D Ferro; F Violi; C Quintarelli; A Sebastianelli; R D'Amelio; L Zichella; F Balsano
Journal:  BMJ       Date:  1992-08-29

2.  Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.

Authors:  D Ferro; M Saliola; C Quintarelli; G Valesini; S Basili; A M Grandilli; M S Bonavita; F Violi
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

Review 3.  The role of antiphospholipid antibodies (aPls) in infertile women: the long-lasting experience.

Authors:  Zdenka Ulcova-Gallova
Journal:  Reprod Med Biol       Date:  2014-10-07

4.  Trends in immunoglobulin G anticardiolipin antibodies in ten successful heparin-treated pregnancies.

Authors:  A Ruffatti; M P Scapinello; S Tonetto; L Di Lenardo; A Piccoli; P Grella; S Todesco
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

5.  Antiphospholipid antibodies associated with implantation failure after IVF/ET.

Authors:  C B Coulam; B D Kaider; A S Kaider; P Janowicz; R G Roussev
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

6.  Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia.

Authors:  T Yamamoto; S Yoshimura; Y Geshi; Y Sasamori; S Okinaga; T Kobayashi; H Mori
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.